TickerKhojMirae Asset Mutual Fund · Equity · Sectoral / Thematic · Direct plan
Mirae Asset Healthcare Fund - Direct Plan - Growth
In plain words
Over 3 years it returned +23.9% a year, against +7.4% for its benchmark index.
Its worst fall from a peak in the last 3 years was -15.9%.
On 3-year return it ranks 6 of 139 funds in Sectoral / Thematic.
A monthly SIP over 5 years ended ₹41,130 higher in the direct plan than the regular plan, because of the lower expense ratio.
Past returns, not a promise of future returns or a recommendation.
Returns vs benchmark
| Period | Fund | Benchmark |
|---|---|---|
| 1 month | +1.2% | +1.9% |
| 3 months | +0.7% | -5.1% |
| 6 months | +14.1% | -3.2% |
| 1 year | +18.5% | -10.2% |
| 3 years (yearly) | +23.9% | +7.4% |
| 5 years (yearly) | +16.6% | +6.5% |
| Since start (yearly) | +21.7% | +11.2% |
Monthly SIP of ₹10,000
| Period | Invested | Value now | Yearly return |
|---|---|---|---|
| 1 year | ₹1,20,000 | ₹1,37,118 | +24.0% |
| 3 years | ₹3,60,000 | ₹4,74,876 | +17.9% |
| 5 years | ₹5,90,000 | ₹9,80,477 | +20.2% |
Top holdings (30 Sept 2026)
Fund size ₹3,494 crore · 30 holdings · 100% in equity
| Company | Industry | Weight |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 10.15% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 9.79% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 6.80% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | 5.62% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | 5.51% |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 4.84% |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 4.78% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | 3.78% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | 3.76% |
| IPCA Laboratories Ltd. | Pharmaceuticals & Biotechnology | 3.39% |
| Krishna Institute of Medical Sciences Ltd. | Healthcare Services | 3.39% |
| Aster DM Quality Care Ltd. | Healthcare Services | 3.32% |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | 3.23% |
| Onesource Specialty Pharma Ltd. | Pharmaceuticals & Biotechnology | 3.01% |
| Fortis Healthcare Ltd. | Healthcare Services | 2.94% |
Largest industries: Pharmaceuticals & Biotechnology 75.8%, Healthcare Services 20.5%, Chemicals & Petrochemicals 1.9%, Healthcare Equipment & Supplies 1.8%, Other 0.0%.
Other plan of this fund: Mirae Asset Healthcare Fund - Regular Plan - Growth